TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.03%17.7B | 0.78%36.35B | 0.67%16.85B | 1.72%36.07B | -7.00%16.74B | -1.47%35.46B | -1.55%18B | -4.10%35.98B | 8.43%18.28B | -3.42%37.52B |
Operating income | 5.03%17.7B | 0.78%36.35B | 0.67%16.85B | 1.72%36.07B | -7.00%16.74B | -1.47%35.46B | -1.55%18B | -4.10%35.98B | 8.43%18.28B | -3.42%37.52B |
Cost of sales | -7.80%-8.94B | -1.13%-18.12B | -1.75%-8.29B | -1.07%-17.91B | 16.88%-8.15B | 7.63%-17.73B | -1.19%-9.8B | -1.49%-19.19B | -18.90%-9.69B | 8.41%-18.91B |
Operating expenses | -7.80%-8.94B | -1.13%-18.12B | -1.75%-8.29B | -1.07%-17.91B | 16.88%-8.15B | 7.63%-17.73B | -1.19%-9.8B | -1.49%-19.19B | -18.90%-9.69B | 8.41%-18.91B |
Gross profit | 2.35%8.76B | 0.44%18.23B | -0.36%8.56B | 2.37%18.15B | 4.82%8.59B | 5.57%17.73B | -4.63%8.19B | -9.77%16.8B | -1.35%8.59B | 2.23%18.61B |
Administrative expenses | -0.40%-6.76B | 1.73%-13.27B | 0.47%-6.73B | -2.42%-13.5B | -6.62%-6.77B | -4.99%-13.18B | 8.04%-6.35B | 6.75%-12.55B | -2.40%-6.9B | -3.79%-13.46B |
Operating interest expense | ---- | -45.73%-2.66B | ---- | -30.34%-1.83B | -4.95%-721M | 14.47%-1.4B | 31.16%-687M | ---1.64B | ---998M | ---- |
Special items of operating profit | -15.60%184M | 792.00%446M | -39.28%218M | 108.33%50M | 715.91%359M | 104.84%24M | 269.23%44M | -199.60%-496M | -106.10%-26M | -22.55%498M |
Operating profit | 6.86%2.18B | -4.38%2.75B | 39.77%2.04B | -9.36%2.88B | 21.24%1.46B | 50.57%3.17B | 80.66%1.21B | -62.69%2.11B | -72.17%667M | -3.93%5.65B |
Financing income | -21.84%68M | ---- | --87M | ---- | ---- | ---- | ---- | ---- | ---- | -35.82%86M |
Financing cost | -20.56%-1.39B | ---- | ---1.15B | ---- | ---- | ---- | ---- | ---- | ---- | -3.11%-1.96B |
Share of profits of associates | -88.17%-175M | 9.23%-236M | 39.22%-93M | -144.07%-260M | -665.00%-153M | 9,933.33%590M | -100.00%-20M | -111.11%-6M | -145.45%-10M | -44.33%54M |
Share of profit from joint venture company | 11.11%-8M | 11.11%-16M | 0.00%-9M | 0.00%-18M | 10.00%-9M | 5.26%-18M | -11.11%-10M | 9.52%-19M | 25.00%-9M | 27.59%-21M |
Earning before tax | -22.54%677M | -3.85%2.5B | -32.72%874M | -30.62%2.6B | 10.55%1.3B | 79.84%3.75B | 81.33%1.18B | -45.34%2.08B | -57.42%648M | -8.91%3.81B |
Tax | 9.94%-326M | 39.14%-409M | 23.63%-362M | 32.67%-672M | -8.72%-474M | -41.56%-998M | -10.66%-436M | 25.08%-705M | 6.86%-394M | 17.02%-941M |
After-tax profit from continuing operations | -31.45%351M | 8.46%2.09B | -37.94%512M | -29.88%1.93B | 11.64%825M | 99.42%2.75B | 190.94%739M | -51.99%1.38B | -76.89%254M | -5.90%2.87B |
After-tax profit from non-continuing business | ---- | ---- | ---- | 319.10%834M | 129.20%106M | 127.30%199M | ---363M | ---729M | ---- | ---- |
Earning after tax | -31.45%351M | -24.30%2.09B | -45.01%512M | -6.31%2.76B | 147.61%931M | 354.08%2.95B | 48.03%376M | -77.39%649M | -76.89%254M | -5.90%2.87B |
Minority profit | -20.91%696M | -1.77%2.33B | -2.33%880M | 40.78%2.37B | 54.81%901M | 0.78%1.68B | -30.55%582M | -23.76%1.67B | -10.47%838M | 1.67%2.19B |
Shareholders should account for profits from continuing business | ---- | 30.33%-471M | ---- | -334.72%-676M | 13.00%-194M | 154.03%288M | ---223M | ---533M | ---- | ---- |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | 11.05%834M | 215.22%106M | 254.21%751M | ---92M | ---487M | ---- | ---- |
Profit attributable to shareholders | 6.25%-345M | -160.05%-236M | -1,326.67%-368M | -68.93%393M | 114.56%30M | 224.02%1.27B | 64.73%-206M | -249.78%-1.02B | -458.28%-584M | -24.08%681M |
Basic earnings per share | 4.93%-0.0598 | -397.56%-0.061 | -451.75%-0.0629 | -84.77%0.0205 | 72.06%-0.0114 | 201.82%0.1346 | 46.10%-0.0408 | -249.72%-0.1322 | -458.77%-0.0757 | -24.08%0.0883 |
Diluted earnings per share | 4.93%-0.0598 | -399.02%-0.061 | -451.75%-0.0629 | -84.82%0.0204 | 72.06%-0.0114 | 201.66%0.1344 | 46.10%-0.0408 | -249.89%-0.1322 | -458.77%-0.0757 | -24.10%0.0882 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.